window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Technology and platforms

    Nanexa secures Japanese patent for PharmaShell technology

    Nanexa has received approval for a Japanese patent covering a [...]

    September 23, 2025
  • Cell & Gene Therapy,Pharmaceuticals and therapeutics,Research & Development,RNA Therapeutics,Technology and platforms

    N4 Pharma advances targeted RNA delivery with SRI collaboration

    N4 Pharma plc, the UK biotech developing its proprietary Nuvec® [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    eXmoor Pharma and Siam Bioscience partner to expand cell and gene therapy services in Southeast Asia

    eXmoor Pharma and Siam Bioscience have announced a strategic partnership [...]

    September 23, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Drug Development,Movers & Shakers,Pharmaceuticals and therapeutics,Technology and platforms

    DaltonTx raises £4 million seed financing to build AI-enabled drug discovery platform

    DaltonTx, a UK-based technology company, has exited stealth mode and [...]

    September 23, 2025
  • Clinical Trials,Data Management,Drug Development,Medical devices,Technology and platforms

    Arkivum partners with PHARMASEAL to enhance unified trial management platform

    Arkivum has announced a partnership with PHARMASEAL, provider of the [...]

    September 23, 2025
  • Medical devices,Movers & Shakers,Pharmaceuticals and therapeutics,Technology and platforms

    Oral BioLife appoints Greg Ambra as CEO and strengthens leadership team

    Oral BioLife, a regenerative technology company developing non-invasive therapies to [...]

    September 23, 2025
  • Middle East,Technology and platforms,Women's Health

    Abu Dhabi Biobank expands access to cord blood banking through NMC Healthcare partnership

    Abu Dhabi Biobank has partnered with NMC Healthcare to expand [...]

    September 22, 2025
  • CDMOs & Manufacturing,Genomics and sequencing,Partnerships & Funding,Research & Development,Technology and platforms

    BioIVT opens new lab facility in Woodbury, New York

    BioIVT has expanded its operations with a new office and [...]

    September 20, 2025
  • Data Management,Genomics and sequencing,Partnerships & Funding,Technology and platforms

    Sapio Sciences and Ultima Genomics partner on integrated multi-omics workflows

    Sapio Sciences has entered a strategic partnership with Ultima Genomics [...]

    September 20, 2025
  • Clinical Development,European biotech,Oncology,Regulatory Affairs,Technology and platforms

    Lithuania’s vice minister Daniel Naumovas on health innovation: “We want patients to feel they can get the best treatment here”

    Daniel Naumovas is a scientist, a teacher and, at 31, [...]

    September 20, 2025
Previous121314Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program
    Categories: Cardiovascular diseases, Clinical Trials, Rare Diseases, Regulatory Affairs, Research & Development
  • City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism
    Categories: Clinical Trials, Neurosciences, Partnerships & Funding, Research & Development
  • BIOGRUND and Seprify launch plant-based tablet coating to replace titanium dioxide
    Categories: Ingredients, Manufacturing, Packaging, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top